Representing Fortune 250 companies, leading private equity sponsors, and other prominent clients, Harry T. Robins advises on mergers and acquisitions (M&A), and joint venture transactions before the US Federal Trade Commission (FTC), Department of Justice (DOJ), state Attorneys General, and international regulatory agencies. He frequently serves in leadership roles in obtaining antitrust approvals in complex transactions for his clients. He also has defended numerous clients in litigated antitrust cases and in government investigations.
Harry frequently represents clients in transactional antitrust matters when Morgan Lewis is not retained for the corporate work on the deal; destination clients of Harry’s include Apollo Management, BHP Billiton, HSBC N.A., Merck & Co. Inc., Perrigo Company plc, and Pfizer Inc.
Among his victories for pharmaceutical industry clients, this year Harry earned an antitrust clearance following an FTC investigation for Merck & Co. Inc. in connection with its $2 billion collaboration with Bayer AG before the FTC, which was part of Merck’s $16 billion sale of its consumer products business. He represented Pfizer Inc. in numerous FTC matters—winning antitrust approval for the pharmaceutical giant’s $4 billion acquisition of King Pharmaceuticals, its $68 billion purchase of Wyeth, and more recently in connection with Pfizer’s $360 million acquisition of InnoPharma.
With respect to litigation, Harry has represented HSBC Holdings, the British international and financial services company, in major foreign currency exchange class action litigation before the US District Court in the Southern District of New York (SDNY). Also on behalf of HSBC, he negotiated a settlement in a multidefendant antitrust case that avoided payment for damages. In another SDNY matter—this one involving two medical device companies—he helped secure a motion to dismiss a complex tying claim. Additionally, he represented Tolko Industries in connection with the oriented strand board class action litigation in the Eastern District of Pennsylvania.
Due to his knowledge and experience with the Hart-Scott-Rodino Act, Harry is often quoted in the media about issues involved in this landmark antitrust legislation. His analysis of the FTC’s proposed changes to Hart-Scott-Rodino premerger rules appeared in the publications Compliance Week and CFO.
Harry writes and speaks on antitrust matters, including a speaking engagement in a panel presentation on “Price Maintenance after Visa/MasterCard” during the Canadian Bar Association’s 2013 competition spring forum. He also delivered presentations at the ABA business law section on “Proposed Changes to the Hart-Scott-Rodino Act Rules.” He presented “Mergers—Nuts & Bolts, Distribution Practices & Competitor Collaborations in the United States: Spotting the Issues for Business Lawyers” at the ABA’s annual meeting in Toronto.
American University, Washington College of Law, 1996, J.D., With Honors
Columbia University, 1990, B.A.
U.S. Court of Appeals for the Second Circuit
U.S. District Court for the Southern District of New York
Awards and Affiliations
Member, American Bar Association, Antitrust Section
Executive Member, New York State Antitrust Bar Committee
Former Member, Association of the Bar of the City of New York, Antitrust and Trade Regulation Committee
Listed, Chambers USA: America's Leading Lawyers for Business (2010–2015)
Listed, Global Competition Review's Who's Who Legal: Competition (2013–2015)
Listed, The Legal 500 US Guide for Antitrust: Merger Control (2015)